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Abstract
Purpose Anxiety disorders are common. Between 1998 and 2008, in the UK, GP recording of anxiety symptoms increased, 
but the recording of anxiety disorders decreased. We do not know whether such trends have continued. This study examined 
recent trends in the recording of anxiety and explored factors that may influence GPs’ coding of anxiety.
Methods We used data from adults (n = 2,569,153) registered with UK general practices (n = 176) that contributed to the 
Clinical Practice Research Datalink between 2003 and 2018. Incidence rates and 95% confidence intervals were calculated 
for recorded anxiety symptoms and diagnoses and were stratified by age and gender. Joinpoint regression was used to estimate 
the years trends changed. In addition, in-depth interviews were conducted with 15 GPs to explore their views and manage-
ment of anxiety. Interviews were audio-recorded, transcribed verbatim and analysed thematically.
Results The incidence of anxiety symptoms rose from 6.2/1000 person-years at risk (PYAR) in 2003 to 14.7/1000 PYAR in 
2018. Between 2003 and 2008, the incidence of anxiety diagnoses fell from 13.2 to 10.1/1000 PYAR; markedly increasing 
between 2013 and 2018 to 15.3/1000 PYAR. GPs mentioned that they preferred using symptom codes to diagnostic codes to 
avoid assigning potentially stigmatising or unhelpful labels, and commented on a rise in anxiety in recent years, especially 
in young adults.
Conclusion Recent increases in the recording of both anxiety diagnoses and symptoms may reflect increased presentation 
to primary care, especially in young adults. There is a clear need to understand the reasons for this, and this knowledge may 
be critical in the prevention and treatment of anxiety.
Keywords General practice · Primary care · Trends · Anxiety disorders · Mental health · Multi-methods
Introduction
Anxiety disorders are common. Within the European Union, 
approximately 38.2% of the population experience a mental 
disorder each year, of which anxiety is the most prevalent 
(14%) [1]. In UK general practice, the prevalence (7.2%) 
and incidence (9.7 per 1000 person-years) of anxiety dis-
orders is high [2]. There is evidence that how GPs record 
presentations of anxiety have changed over time. Between 
1998 and 2008, GP recording of anxiety symptoms increased 
(3.9/1000 PYAR to 5.8/1000 PYAR), whereas recording of 
anxiety disorders decreased (7.9/1000 PYAR to 4.9/1000 
PYAR) [3]. Others have also reported an increase in symp-
tom codes for anxiety and depression combined [4] and a 
recent increase in anxiety codes (1998–2018)[5]. However, 
Slee et al. [5] focused on generalised anxiety disorder (GAD) 
and combined symptom and diagnosis codes. Hence no data 
are available on whether GP recording of presentations of 
anxiety in UK primary care has changed in recent years.
Several factors may have impacted incidence rates and 
changed how GPs record anxiety: the 2006 depression Qual-
ity Outcomes Framework (QOF) [6]; the Improving Access 
to Psychological Therapies (IAPT) service introduced in 
2007/2008; the 2008 recession; and the 2011 NICE anxiety 
guidelines [7]. The latter recommended that “recognition 
and communication of the diagnosis of GAD should occur 
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as early as possible to help people understand the disorder 
and start effective treatment promptly” (page 7) [7].
The fall in recorded anxiety diagnoses [3] may be due to 
a reluctance by GPs to formally label patients with an anxi-
ety disorder, or a preference for using broad symptom codes 
rather than distinguishing between the subtypes of anxiety 
[8, 9]. However, the reasons are unclear as few UK studies 
have explored GP views on the diagnosis of anxiety.
The aim of this study was to examine trends in the record-
ing of anxiety in UK primary care between 2003 and 2018 
using Clinical Practice Research Datalink (CPRD) data and 
to investigate whether there were differences according to 
age and gender. In addition, qualitative interviews with GPs 
were conducted alongside this study to provide insight into 
possible reasons for the trends observed.
Methods
Data source
The CPRD GOLD is a large database of anonymised UK 
primary care electronic records and is considered broadly 
representative of the UK population regarding gender and 
age [10, 11]. Contributing practices use Vision practice 
management software [12]. For each registered patient, the 
record contains information including consultation dates and 
prescriptions. At the time of conducting this research, prac-
tices sampled used the READ code system [13] to record 
symptoms or diagnoses. These codes may be recorded by 
either GPs or practice nurses.
Study population
We used data from adults aged 18 years and over, regis-
tered at a CPRD practice between 1st January 2003 and 31st 
December 2018. CPRD assigns quality metrics: ‘accept-
able’ patient records are those with valid registration and 
demographic information, with no breaks in the record; and 
‘up-to-standard’ practices are those with continuous accu-
rate recording of data, including patient deaths or transfers 
out of practice [11]. Patient records had to be ‘acceptable’ 
and from practices that were ‘up-to-standard’ for at least 
one year prior to the study entry date. Practices had to have 
contributed data for the entire study period. Patients with 
a recorded anxiety code had to have been registered with 
CPRD for one year before the first recorded code to ensure 
high-quality assessment of incident cases.
Codes for anxiety
Those with a recorded anxiety diagnosis and/or recorded 
symptoms of anxiety were identified using codes compiled 
from the NHS Anxiety READ Codes (Version 3, April 
2018), and cross-checked with code lists from previous epi-
demiological research [3, 4] (Supplement 1). This included 
using code lists created in these previous studies to deline-
ate between anxiety symptoms and anxiety disorders for the 
present study [3, 4]. These lists were then reviewed by a GP, 
with no further codes added or excluded. All authors agreed 
on the final list. Codes for obsessive–compulsive disorder 
and post-traumatic stress disorder were excluded as these 
disorders are no longer included as ‘anxiety disorders’ in the 
Diagnostic and Statistical Manual (DSM-5) [3, 4, 14, 15]. 
We did not include phobias as our focus was on generalised 
anxiety disorder and related disorders, rather than specific 
phobias, which would require a different treatment approach.
Statistical analysis
Data analysis was conducted using Stata version 15.1 [16].
Incident use of codes in each calendar year was exam-
ined in terms of those with a new episode defined by: (1) 
any anxiety code (symptom or diagnosis); (2) a diagnosis 
code; and (3) a symptom code. A new episode was defined 
as a recorded symptom or diagnosis of anxiety in that year, 
with no prior recorded code of that category recorded in the 
previous 12 months. Patients could have more than one new 
episode within the study period provided that there was a 
minimum of 12 months between episodes.
Annual incidence rates were calculated by dividing the 
number of incident cases by the total person-years at risk 
(PYAR) for each calendar year, and are presented per 1000 
PYAR. Data were stratified by age (< 25, 25–34, 35–44, 
45–54, 55–64, 65–74, 75–84, ≥ 85 years) and gender. Esti-
mates of 95% confidence intervals (95% CI) for these rates 
were calculated based on the Poisson distribution.
Univariable Poisson regression models were used to 
examine the association between year of recording, age, 
gender, and incidence of anxiety symptoms/diagnoses. Inci-
dence rate ratios (IRRs) and 95% CIs are reported. Multi-
variable Poisson regression models that included year, age 
and gender were used to examine the independent effects of 
such factors. Sensitivity analyses were conducted to account 
for any clustering within practices within the multivaria-
ble model. To formally test whether incidence varied over 
time according to age and gender, the multivariable Pois-
son regression model was repeated including an interaction 
between gender and year, and age and year.
Changes in trends over time were examined using join-
point regression (version 4.7.0.0) (National Cancer Institute, 
2020). By fitting a series of joined straight lines, the model 
selects the point(s) at which there is a significant increase/
decrease in the rate (joinpoints) thus identifying the years 
(with 95% CI) at which changes in trends occurred. The 
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annual percentage change (APC), based on the slope of each 
line between joinpoints, was also calculated.
Additional analysis were undertaken grouping diagno-
sis codes based on ICD-10 classification [17] in terms of 
generalised anxiety (GAD), mixed anxiety and depression 
(MADD), or panic attacks or disorders (Panic). Annual inci-
dence rates (and 95% CI) were calculated for each diagnostic 
group as described earlier.
Qualitative interviews
Recruitment, sampling, and data collection
Practices in Bristol and the surrounding area were informed 
about the study by the Clinical Research Network. GPs 
willing to be interviewed completed a response form and 
emailed it to the research team. GPs were purposively sam-
pled to achieve maximum variation in relation to gender, age 
and length of time working in primary care. GPs were also 
sampled based on practice deprivation decile, and socio-
demographic characteristics of their patients.
GPs were interviewed by CA, having given informed con-
sent to participate. A topic guide was used to ensure consist-
ency across the interviews, with interviewees asked about 
causes of anxiety and the codes they use. For full details see 
Archer et al. [18].
Data analysis
Data collection and analysis proceeded in parallel so that 
initial interviews informed later interviews. Data collection 
ended when data saturation was reached (no new themes 
identified). Interviews were audio-recorded, transcribed ver-
batim, anonymised, and checked for accuracy.
Data were analysed thematically [19]. CA and KT inde-
pendently coded a sub-set of transcripts, and then compared 
and discussed their coding and interpretation of the data. A 
preliminary coding framework was developed, which was 
revised as new codes were identified in later transcripts. 
All transcripts were coded electronically in NVivo (version 
12) [20]. Data under specific codes were then retrieved, and 
read and compared to identify key themes and deviant cases. 





The dataset included 176 practices with 2,569,153 eligible 
patients registered across the 16-year period (2003–2018), 
and 17.6 million person-years of follow-up (PYFU). Over 
the study, there were 264,127 incident anxiety codes 
(any anxiety code) recorded; 216,126 new episodes of 
anxiety diagnoses; and 197,217 new episodes of anxiety 
symptoms.
GP use of anxiety codes
GPs used a large number of READ codes (Table  1). 
The most frequently used diagnostic codes were ‘anxi-
ety states’, ‘anxiety with depression’, and ‘panic attack’, 
totalling 82.6% (n = 178,488/216,126) anxiety diagno-
sis episodes. ICD-10 diagnostic codes were used infre-
quently, with ‘generalised anxiety disorder’ and ‘mixed 
anxiety and depressive disorder’ each representing less 
than 2% (n = 3,482/216,126; n = 3,735/216,126) of diag-
nostic codes. When diagnostic codes were grouped, codes 
relating to GAD accounted for more than half of diagno-
sis codes used by GPs, with a further 31% attributed to 
the MADD category. When recording anxiety symptoms, 
‘anxiousness symptom’, ‘anxiousness’, and ‘worried’, 
were used in the majority (n = 192,243; 97.5%) of anxiety 
symptom episodes.
Trends in coding over time
The incidence of any anxiety code rose from 17.8/1000 
PYAR in 2003 to 28.5/1000 PYAR in 2018. Between 
2003 and 2008, the incidence of anxiety diagnoses fell 
from 13.2/1000 PYAR to 10. 1/1000 PYAR; after which 
incidence remained fairly constant, before increasing in 
recent years (Table 2 and Fig. 1). The incidence of anxiety 
symptoms more than doubled over the entire study period 
rising from 6.2/1000 PYAR in 2003 to 14.7/1000 PYAR 
in 2018 (Table 2 and Fig. 1).
The best-fitting joinpoint model for any anxiety codes 
included one joinpoint at 2011 [with 95% confidence 
that the joinpoint was between 2009 and 2014 (95% CI 
2009–2014)], after which incidence substantially increased 
(Supplement 2). For diagnosis codes, the best fitting model 
included two joinpoints: one in 2008 (95% CI 2006–2011), 
after which incidence remained fairly constant, and one 
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Table 1  Frequency of Read 
codes used by GPs to record 




Diagnosis codes Anxiety states 93,989 43.5
Anxiety with depression 61,831 28.6
Panic attack 22,668 10.5
Anxiety state NOS 7,301 3.4
Panic disorder 5,740 2.7
[X] Mixed anxiety and depressive disorder 3,735 1.7
Generalised anxiety disorder 3,482 1.6
Chronic anxiety 3,125 1.5
Anxiety state unspecified 3,095 1.4
Agoraphobia with panic attacks 1,879 0.9
[X] Anxiety disorder, unspecified 1,549 0.7
[X] Mild anxiety depression 1,091 0.5
[X] Anxiety NOS 991 0.5
[X] Other anxiety disorders 984 0.5
[X] Generalised anxiety disorders 928 0.4
Recurrent anxiety 703 0.3
[X] Agoraphobia 630 0.3
[X] Panic attack 528 0.2
[X] Panic disorder (episodic paroxysmal anxiety] 430 0.2
[X] Social phobias 410 0.2
Social phobic disorders 226 0.1
[X] Persistent anxiety depression 204 0.1
Agoraphobia without mention of panic attack 153 0.1
[X] Anxiety state 140 0.1
[X] Anxiety neurosis 135 0.1
[X] Panic state 83 0.0
[X] Panic disorder with agoraphobia 49 0.0
[X] Other mixed anxiety disorders 29 0.0
[X] Other specified anxiety disorders 12 0.0
[X] Agoraphobia without history of panic disorder 3 0.0




Generalised anxiety (GAD) 112,898 52.2
Mixed anxiety and depression (MADD) 66,861 30.9
Panic attack or disorder (PANIC) 29,449 13.6
Other anxiety codes 6,918 3.2
Total 216,126 100







O/E panic attack 64 0.0
Nervous—nervousness 19 0.0
Total 197,217 100
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in 2013 (95% CI 2011–2016), after which incidence sub-
stantially increased (Supplement 4). For symptom codes, 
the best fitting model had one joinpoint at 2007 (95% CI 
2005–2009), after which incidence continued to increase, 
but at a slower rate compared with earlier years (Supple-
ment 5).
After adjusting for age and gender, the IRR for any anxi-
ety code was 1.65 (95% CI 1.63–1.68) when comparing 
2018 with 2003 (Supplement 5). For symptom codes, after 
adjusting for age and gender, incidence more than doubled 
[IRR 2.41 (95% CI 2.34–2.48)] when comparing 2018 with 
2003 (Supplement 7).
Recorded incidence of anxiety in females was nearly 
twice that of males (Supplement 5–7). This was consist-
ent across any anxiety code, anxiety diagnoses and anxiety 
symptoms [adjusted IRR: females compared with males: any 
anxiety code IRR 2.13 (95% CI 2.11–2.14); diagnosis codes 
IRR 2.07 (95% CI 2.05–2.09); symptom codes IRR 2.12 
(95% CI 2.10–2.14)] (Supplement 5–7).
Recorded incidence of anxiety (any code) decreased with 
age, with incidence for those aged ≥ 85 being just over half 
(IRR: 0.58 (95% CI: 0.57–0.60)) that of those aged < 25 
(Supplement 5). A similar pattern was found for recorded 
incidence for anxiety diagnoses (Supplement 7), with the 
incidence for those aged ≥ 85 being approximately half 
[IRR: 0.48 (95% CI: 0.46–0.50)] that of those aged < 25, and 
for anxiety symptoms (Supplement 6), with a 30% reduc-
tion in the incidence of anxiety for the oldest age group 
compared with the youngest age group [IRR: 0.67 (95% CI 
0.65–0.69)].
Findings from sensitivity analyses examining the poten-
tial impact of clustering within GP practices were consistent 
with the results from models that did not allow for clustering 
(data not shown). IRRs were the same, although confidence 
intervals were slightly wider.
Trends in coding over time by gender and age
Whilst the recorded incidence of anxiety was more com-
mon in females, the overall pattern of trends over time (any 
anxiety code, diagnoses and symptoms) were similar for 
males and females (Supplement 8–10). There was no evi-
dence of an interaction between year and gender for any 
anxiety code (p value for interaction = 0.38). Whilst there 
was evidence of an interaction between year and gender for 
diagnosis codes (p < 0.001) and (weakly for) symptom codes 
(p = 0.053), the differences were small and unlikely to be 
clinically meaningful.
When stratified by age, recorded incidence increased sub-
stantially in younger age groups in later years of the study 
(Fig. 2 and Supplement 11 and 12). There was strong evi-
dence of an interaction between year and age for all models 
(any anxiety code, diagnosis, and symptoms: p value for 
interaction < 0.001).
There was a marked increase in the recorded incidence 
of anxiety diagnosis between 2013 and2018 in the two 
youngest age bands, increasing from 11.8/1000 PYAR to 
24.4/1000 PYAR for under 25 s and from 13.1/1000 PYAR 
to 22.7/1000 PYAR for those aged 25–34. Incidence of 
anxiety diagnosis fell between 2003 and 2018 in the oldest 
Fig. 1  Trends in the incidence 
of GP recorded anxiety (any 
code, diagnosis, and symptom 
codes) between 2003 and 2018
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age groups, decreasing from 10. 5/1000 PYAR to 8.1/1000 
PYAR for those aged 75–84, and from 8.4/1000 PYAR to 
6.1/1000 PYAR for those aged ≥ 85 (Supplement 11).
There was a marked increase in the recorded incidence 
of anxiety symptoms over the duration of the study for the 
two youngest age bands, increasing from 4.6/1000 PYAR 
to 22.2/1000 PYAR for under 25 s and from 5.7/1000 
PYAR to 21.2/1000 PYAR for those aged 25–34. In con-
trast, whilst the incidence of anxiety symptoms increased 
over the first half of the study period for the oldest age 
groups (65–74, 75–84, and ≥ 85 years), incidence then 
decreased in the second half (Supplement 12).
Fig. 2  Incidence of GP recorded 
anxiety (any anxiety code) per 
1000 PYAR, by age
Fig. 3  Trends in the incidence 
of GP recorded anxiety—any 
diagnosis code, generalised 
anxiety (GAD), mixed anxiety 
and depression (MADD), and 
panic attack/disorder (Panic)—
between 2003 and 2018
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Trends in coding over time of diagnosis subtypes
Trends over time in the diagnosis subtype groups were also 
examined (Fig. 3 and Supplement 13). Between 2003 and 
2008, the incidence of GAD fell from 7.0 to 5.3/1000 PYAR; 
increasing over subsequent years to 8.2/1000 PYAR in 2018 
(Fig. 3 and Supplement 13). The incidence of MADD gradu-
ally decreased from 4.8/1000 PYAR in 2003 to 2.9/1000 
PYAR in 2011; and then increased to 6.2/1000 PYAR in 
2018 (Fig. 3 and Supplement 13). Between 2003 and 2018, 
the incidence of Panic gradually declined from 2.4/1000 
PYAR to 1.0/1000 PYAR (Fig. 3 and Supplement 13).
Qualitative interviews
Fifteen GPs from six GP practices were interviewed 
between September 2018 and March 2019. The mean age 
was 44.9 years (SD 7.7) and eight interviewees were female 
(53.3%). Those interviewed had been consulting in gen-
eral practice between 4 and 27 years. The analysis focused 
on identifying factors that may explain the trends seen in 
GP coding of anxiety. Possible reasons for these trends are 
detailed below.
Recent increases in anxiety
GPs commented that the number of patients presenting with 
anxiety had increased over time, and this had increased GP 
awareness of anxiety. They suggested that increasing internet 
use for shopping, working, and interacting meant “people 
are becoming more isolated…they’re not having to go out…
[and] interact with people as much” (GP 15) and lacked 
‘real-life’ social support. GPs stated that social media may 
skew perceptions of what real life is like and made it much 
easier to make comparisons with others’ lives, and that this 
could be a factor in the increase in anxiety.
“Social media…this perception that everyone should 
have this perfect life, perfect looks, perfect body, per-
fect house, perfect holidays...the reality is that not eve-
ryone has…I think that’s what’s feeding an anxiety 
boom.” GP 1
GPs reported that they had seen a recent increase in 
patients aged  “18–25” (GP 11) presenting with anxiety, 
notably in the past five years.
“I’ve been a GP for 20 years and the incidence of anxi-
ety seems to be on the increase, especially in the last 
five years, especially in younger people.” GP 12
They suggested this could be driven by social media, and 
by “an awful lot more pressure, or perceived pressure…to 
either perform or to do things” (GP 12), such as “exam…
social…work performance” (GP 7). GPs commented that 
this could be compounded by online gaming. They are living 
in a “virtual world [that] is not the real world…losing social 
and physical contact…it makes them anxious about going 
out and [having] social contact.” (GP 13).
GPs stated that they felt in recent years there had been 
increased awareness of anxiety in the media and by celebri-
ties, with “greater recognition from the public of their symp-
toms, less stigma, and [therefore more likely to] seek help” 
(GP 1). They explained that this meant patients often knew 
they ‘had’ anxiety and would “specifically raise the ques-
tion themselves” (GP 4). Therefore, there was potentially an 
expectation that the GP ‘had’ to “medicalise” (GP 11) their 
symptoms and give a label of anxiety.
“By the time it gets to us we’re probably over-pathol-
ogising it, because we’re seeing it so we’re kind of 
feeling we have to do something about it…it’s quite 
difficult just to say that’s normal, don’t worry about 
it.” GP 2
Coding choice and influences
GPs commented they that used codes such as “anxiety 
states” (GP 9) to cover a general sense of anxiety, rather 
than ICD-10 codes. GPs talked about progressing to other 
diagnostic codes when they had more information during 
follow-up consultations, such as “generalised anxiety…or…
chronic anxiety if they’d had [past] episodes” (GP 10). How-
ever, some GPs talked about using codes interchangeably, 
with a tendency to select whichever anxiety code presented 
first on the list—“whatever comes up first, that’s a code for 
anxiety, that’ll do” (GP 2). When talking about anxiety and 
depression presenting co-morbidly, GPs reported a tendency 
to code for both conditions “under the umbrella of depres-
sion” (GP 11).
“It can be difficult if someone’s depressed and hav-
ing panic attacks, and I think the majority I do put as 
depression, but if someone has predominantly anxi-
ety then I will classify them often as depression with 
anxiety.” GP 12
GPs preferred to use symptoms codes rather than label 
patients with an anxiety disorder because they thought they 
could be stigmatising, or because patients “don’t want to be 
given a diagnosis” (GP 4). Several GPs stated that coding 
for anxiety was particularly unhelpful if “it makes it easier 
for them to assume the sick role…that they’re not getting 
better” (GP 13).
Some GPs mentioned the depression QOF as influencing 
the decision to code for a symptom rather than a disorder. 
Although they referred to depression rather than anxiety, 
there was a sense that the QOF had led to GPs being more 
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cautious about using diagnostic codes across all mental 
health conditions.
“I think QOF…has skewed prevalence rates…because 
now if we write depression [rather than low mood] 
they chastise us if we haven’t done so much within 
a number of weeks… so I tend to be rather cautious 
about labels.” GP 6
Threshold for coding symptom versus diagnosis
GPs reported that severity and chronicity of symptoms were 
used to determine “when to change [the code] to [an] anxi-
ety disorder, where they have chronic…anxiety, like long-
standing” (GP 11), rather than using a symptom code. Some 
GPs suggested they would delay coding for a disorder until 
“six weeks, a month…if they’re still managing to work then 
I probably would delay the diagnosis longer” (GP 1).
Some GPs commented that there was an association 
between coding for an anxiety disorder and prescribing 
medication to treat it. That is, if a patient had reached a 
threshold for being prescribed medication, then they would 
have also reached the threshold for an anxiety diagnosis, 
rather than an anxiety symptom.
“If I was prescribing an SSRI for anxiety without 
depression, I would certainly make a formal diagnosis 
[with a diagnostic code] then.” GP 6
Discussion
Summary
The recorded incidence of anxiety symptoms increased 
between 2003 and 2018. In contrast, the recorded inci-
dence of anxiety diagnoses decreased between 2003 and 
2008, before markedly increasing between 2013 and 2018. 
When subdivided by diagnostic category, GAD and MADD 
showed a similar trend. However, the recorded incidence of 
Panic gradually declined across the 16-years.
Recorded incidence in females was nearly twice that of 
males—for any anxiety code, diagnosis codes, and symp-
tom codes. Recorded incidence—any code, diagnosis, and 
symptoms—increased substantially in the later years of 
the study in younger age groups (18–34 years). There was 
also an increase in recorded incidence in recent years for 
35–54-year-olds, although it was less marked. The recorded 
incidence for the older age groups (≥ 65 years) declined in 
later years.
GPs’ accounts suggested that GPs prefer to use symp-
tom codes to diagnostic codes. Symptom codes were used 
for acute and mild anxiety, and diagnostic codes used for 
chronic and severe anxiety. This may, in part, explain the 
increase in the recorded incidence of anxiety symptoms over 
the study, and the decrease in anxiety diagnoses over the first 
five years. Hence, the trends observed may reflect changes in 
GP recording, rather than solely a change in incidence. How-
ever, GPs also commented on a recent rise in primary care 
presentation of anxiety and suggested a greater awareness 
of anxiety in society as a possible reason for this. This may 
explain the increase in the incidence of recorded diagnostic 
codes in later years. Additionally, the severity or chronic-
ity of anxiety may have increased over recent years, and 
this could also be driving the increasing use of diagnostic 
codes. This increased incidence may also be due to better 
detection of anxiety by GPs and increasing acknowledge-
ment of anxiety as a distinct disorder from depression. Cases 
that would have been previously coded as depression, may 
now being coded as anxiety. GPs commented on increasing 
anxiety in young adults. This is consistent with the increase 
in recorded incidence—of both diagnosis and symptoms—
found in 18–34-year-olds in recent years in the CPRD data. 
GPs suggested this could be due to social media and pressure 
on young adults.
Strengths and limitations
This study reports trends in a large sample that can be con-
sidered representative of the UK population, over a 16-year 
period. An extensive code list was used, compiled from 
national READ code terms, and cross-checked with code 
lists from previous epidemiological research [3]. It is there-
fore likely to capture most anxiety codes used by GPs, and 
prior research has validated such diagnoses recorded by 
GPs in primary care research databases [2]. A multi-method 
approach enabled the exploration of possible reasons for the 
trends observed. Interviews were analysed prior to analysis 
of the CPRD data, and therefore not influenced by knowl-
edge of the quantitative findings. GPs were interviewed who 
varied in terms of age, gender, practice deprivation decile, 
and experience.
In terms of limitations, the quantitative sample is com-
prised of patients with a recorded anxiety code. It is likely 
that there are individuals with anxiety who have discussed 
symptoms with their GP, but have not had it coded within 
their record, or only recorded in free-text. Similarly, indi-
viduals whose anxiety is not detected, or where GPs have 
not coded it separately from depression or physical health 
conditions, will also not be included. Hence, the reported 
figures may be an underestimate of the incidence of anxi-
ety, or the trends seen may be biased if GPs use of free-text 
recording has changed over time. In addition, trends have 
only been reported for those who consult for anxiety. No 
adjustment was made for the level of deprivation, however 
previous research in this area has indicated that adjustment 
for deprivation does not materially affect the reported trends 
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in the coding of anxiety [3]. In terms of the qualitative data, 
the participating GPs were self-selecting. It is possible that 
those interviewed had more of an interest in anxiety than 
those who did not respond to the invitation.
Comparisons with existing literature
Walters et al. [3] examined the incidence of anxiety in pri-
mary care between 1998 and 2008 and found an increase in 
recorded anxiety symptoms. Our findings extend this work 
and show that this trend has continued over the subsequent 
ten years. However, whilst Walters et al. [3] found a decrease 
in the incidence of anxiety disorders between 1998 and 
2008, the present study found that incident anxiety diagnoses 
increased after 2008. When comparing incidence rates for 
the overlapping years (2003–2008), Walters et al. [3] found 
symptom rates rose from 3.9 to 5.8/1000 PYAR, whereas 
higher rates of 6.2–9.6/1000 PYAR were seen in this study. 
The higher rates may be due to the additional READ codes 
included in the present study, that accounted for 11% of 
recorded symptom codes. The decline in the incidence of 
GAD in this study to 2008 (5.3/1000 PYAR) is consistent 
with the recorded decrease in the incidence of GAD codes 
observed at the end of Walters et al. [3] study (4.9/1000 
PYAR in 2008). Similarly, there was a trend of reduced inci-
dence of Panic and MADD during the overlapping years in 
the two studies. Slee et al. [5] examined the incidence of 
GAD in primary care between 1998 and 2018 and found an 
increase in anxiety diagnoses and symptoms combined. Our 
findings of an increase in the incidence of any anxiety code 
between 2003 and 2018 are consistent with this.
John et al. [4] focused on GP coding for anxiety and 
depression between 2000 and 2009 and reported an increase 
in symptom codes, but a stable incidence of diagnosis codes 
[4]. However, this study did not present data for anxiety sep-
arately [4]. Previous research has also shown after the 2006 
QOF was introduced, GP use of depression symptom codes 
increased [21]. Conversely, in the present study, there was 
no corresponding increase in anxiety symptom codes after 
the QOF, rather a reduction in the rate of increase in inci-
dence occurred after 2007. The latter may reflect increasing 
presentation to IAPT (introduced in 2007/2008). However, 
this is unlikely as any changes in incidence would have been 
expected to have been seen over a prolonged period. Whilst 
there are no qualitative data from the previous studies [3–5, 
21] to provide insight into possible reasons for the trends 
seen, previous interview data—based on vignettes—sug-
gests GPs are reluctant to code for an anxiety disorder and 
prefer to use symptom codes where possible [8]. Our inter-
view findings align with this.
However, a preference for using symptom codes does not 
explain why the present study found an increase in diagnos-
tic codes in recent years. This may, in part, be due to the 
impact of the 2008 recession, as diagnosis codes levelled off 
between 2008 and 2013 after a previously sharp decline. Pre-
vious studies have also found reversals in declining suicide 
rates, and increasing rates of depression for several years 
after the recession [22, 23]. It may also be explained by the 
2011 NICE anxiety guidelines, with the recommendation 
for earlier diagnosis increasing awareness among GPs [7]. 
Indeed, this study found an increase in the incidence rate 
of any anxiety code—symptom or diagnosis—after 2011. 
Finally, mental health campaigns may be increasing help-
seeking behaviour. The anti-stigma campaign, ‘Time To 
Change’, led to an increase in intended help-seeking from 
GPs, and an increase in mental health discussion and disclo-
sure [24]. This may also explain the rise in anxiety diagnoses 
(and symptoms) found in the later years of the present study.
The finding of an increased incidence of anxiety in 
females compared with males is consistent with previous 
research in primary care [2, 3]. Martin-Merino et al. [2] 
also found that between 2002 and 2004, the incidence of any 
anxiety code was highest in adults aged 20–29 years. How-
ever, the study did not distinguish between disorder codes 
and symptom codes and included a broader range of READ 
codes, including phobias. The present study has extended 
these findings and found that, in recent years, there has been 
a substantial increase in the recorded incidence of anxiety—
diagnoses and symptoms—in young adults (aged < 35). This 
reflects national survey data, where 16–24-year-olds were 
nearly ten times more likely to report a mental health condi-
tion in 2014, compared with 1995 [25]. The authors suggest 
this may be attributed to social media, increased awareness 
and pressure on this generation. GPs interviewed in the pre-
sent study also endorsed similar reasons [25].
This study predates the COVID-19 pandemic and some 
causes identified by GPs will have intensified, particularly 
social isolation [26]. However, the pandemic may have 
resulted in further increases in anxiety by its impact on vari-
ous groups: those infected with COVID-19 and those expe-
riencing longer-term health consequences (long COVID); 
those with increased health anxiety due to concerns about 
themselves and/or family/friends catching the virus; those 
experiencing financial difficulties due to the economic 
impact; and young adults whose education or career pros-
pects have been affected [27–29]. This impact—at a time 
when the incidence of anxiety was already increasing—may 
have longer-term consequences for individuals and society.
Implications
The incidence of recorded anxiety diagnoses decreased 
between 2003 and 2008, but increased from 2013 to 2018. 
In contrast, the incidence of recorded anxiety symptoms 
increased over the 16-years. The increase in the incidence 
of both diagnosis and symptom codes in recent years was 
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particularly marked in young adults. GP interview data 
suggests the earlier decline in the recording of anxiety 
diagnoses may have been due to a preference for using 
symptom codes, rather than diagnosis codes. However, 
increased awareness of anxiety among patients may be 
increasing primary care presentation, and hence driving 
recent increases in recorded anxiety, especially in young 
adults. GPs suggested that pressure to succeed, and social 
media use, may be contributing to this.
There is a need for future research to understand the 
rise in anxiety seen in recent years—particularly amongst 
young adults. This may be critical in the development of 
interventions for the prevention and treatment of anxiety, 
and ultimately, lead to better outcomes for these patients.
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